328 related articles for article (PubMed ID: 15961077)
1. Plasmodium berghei NK65: studies on the effect of treatment duration and inoculum size on recrudescence.
Nakazawa S
Exp Parasitol; 2005 Sep; 111(1):59-63. PubMed ID: 15961077
[TBL] [Abstract][Full Text] [Related]
2. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
3. Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR mice.
Ishih A; Suzuki T; Watanabe M; Miyase T; Terada M
Phytother Res; 2003 Dec; 17(10):1234-6. PubMed ID: 14669265
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment.
Ishih A; Suzuki T; Muregi FW; Matsui K; Terada M
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium berghei: a new rat model for assessment of blood schizonticidal activity.
Dow GS; Reynoldson JA; Andrew Thompson RC
Exp Parasitol; 1999 Oct; 93(2):92-4. PubMed ID: 10502471
[No Abstract] [Full Text] [Related]
7. Rifampicin antagonizes the effect of choloroquine on chloroquine-resistant Plasmodium berghei in mice.
Hou LJ; Raju SS; Abdulah MS; Nor NM; Ravichandran M
Jpn J Infect Dis; 2004 Oct; 57(5):198-202. PubMed ID: 15507775
[TBL] [Abstract][Full Text] [Related]
8. Schizontocidal effects of oral artesunate on Plasmodium berghei in mice and P knowlesi in monkeys.
Shi YL; Li GF; Zhao JH; Yang JD; Ding DB
Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):755-8. PubMed ID: 10678113
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium berghei: sensitivity of chloroquine-resistant and chloroquine-sensitive strains to irradiation and the effect of irradiated malaria parasites on cytochrome P450-dependent monooxygenases.
Song GH; Andre RG; Scheibel LW; Wirtz RA; Strickman DA; Cheriathundam E; Alvares AP
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):75-86. PubMed ID: 8581351
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium berghei: development of an irreversible experimental malaria model in Wistar rats.
Pedroni HC; Bettoni CC; Spalding SM; Dalla Costa T
Exp Parasitol; 2006 Jul; 113(3):193-6. PubMed ID: 16494867
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antiplasmodial activity of ethanolic seed extract of Picralima nitida.
Okokon JE; Antia BS; Igboasoiyi AC; Essien EE; Mbagwu HO
J Ethnopharmacol; 2007 May; 111(3):464-7. PubMed ID: 17234375
[TBL] [Abstract][Full Text] [Related]
12. [Studies on pharmacokinetics of chloroquine in mice infected with chloroquine-resistant strain of Plasmodium berghei].
Shi J; Song GH; Ni YC; Wang MJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(5):282-5. PubMed ID: 12567636
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of serum of mice infected with chloroquine-resistant 'NS' line to the antimalarial action of chloroquine.
Li GD; Qian YL; Chen L
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):257-60. PubMed ID: 2692400
[TBL] [Abstract][Full Text] [Related]
14. [Effect of trifluoroacetoprimaquine on erythrocytic schizonts of rodent malaria].
Ye X; Shao B; Chu Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(3):223-4. PubMed ID: 7867162
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
[TBL] [Abstract][Full Text] [Related]
16. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
17. Curcumin for malaria therapy.
Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial effect of agmatine on Plasmodium berghei K173 strain.
Su RB; Wei XL; Liu Y; Li J
Acta Pharmacol Sin; 2003 Sep; 24(9):918-22. PubMed ID: 12956942
[TBL] [Abstract][Full Text] [Related]
19. The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity.
Peters W
Ann Trop Med Parasitol; 1975 Jun; 69(2):155-71. PubMed ID: 1098584
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulating effect of a new polyamine (the MAP-1987) administered with chloroquine in plasmodia infected mice.
Földes J; Matyi A
Acta Microbiol Immunol Hung; 1994; 41(1):73-82. PubMed ID: 7921853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
